What makes tuberous sclerosis so complex, is that it is an autosomal-dominant genetic disorder with highly variable expression. The most common neurological expression of TSC is epilepsy. About 85% of those diagnosed with TSC suffer from epileptic seizures. 63% of these patients develop treatment-resistant epilepsy. CBD is found to show efficacy in treating various neurological conditions. It is also non-psychoactive and a safe alternative. It is often used as an antiepileptic treatment. The question remains if it would be enough to treat patients who suffer from refractory seizures of tuberous sclerosis complex.